Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
نویسندگان
چکیده
Cardiovascular disease is one of the main burdens of healthcare systems worldwide. Nevertheless, assessing cardiovascular risk in both apparently healthy individuals and low/high-risk patients remains a difficult issue. Already established biomarkers (e.g. brain natriuretic peptide, troponin) have significantly improved the assessment of major cardiovascular events and diseases but cannot be applied to all patients and in some cases do not provide sufficiently accurate information. In this context, new potential biomarkers that reflect various underlying pathophysiological cardiac and vascular modifications are needed. Also, a multiple biomarker evaluation that shows changes in the cardiovascular state is of interest. This review describes the role of selected markers of vascular inflammation, atherosclerosis, atherothrombosis, endothelial dysfunction and cardiovascular fibrosis in the pathogenesis and prognosis of cardiovascular disease: the potential use of cardiotrophin-1, leptin, adiponectin, resistin and galectin-3 as biomarkers for various cardiovascular conditions is discussed.
منابع مشابه
Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
Heart failure (HF) is multifactorial syndrome with high cardiovascular (CV) morbidity and mortality rates associated with an increasing prevalence worldwide. Measuring plasma levels of circulating biomarkers, i.e., natriuretic peptides, cardiac-specific troponins, metabolomic intermediates, Galectin-3, ST2, cardiotrophin-1, soluble endoglin and growth differentiation factor 15, may assist in th...
متن کاملCan Biomarkers Help to Diagnose Early Heart Failure with Preserved Ejection Fraction?
Early heart failure with preserved ejection fraction (HFpEF) is a frequent disease, but its diagnosis is difficult and relies mostly on the evidence of left ventricular filling pressure (LVFP) elevation during exercise. Several reports have suggested that natriuretic peptides plasma levels reflect exercise-induced increase in LVFP, but they still have significant limitations. In this context, a...
متن کاملDoes Growth-Differentiation Factor-15 Provide Additional Prognostic Information Beyond Conventional Cardiovascular Risk Factors and Biomarkers in Heart Failure?
Heart failure (HF) is reported as a leading cause of premature cardiovascular (CV) death and increased hospitalization rate in patients with established CV disease [1, 2]. Although frequency of newly diagnosed HF in developed countries exhibits a trend to decrease, there is evidence regarding steadily growth of HF patients’ population worldwide [3]. Biological markers are widely used to stratif...
متن کاملEarly Detection of Renal Dysfunction in β Thalassemia with Focus on Novel Biomarkers
Improved survival among transfusion dependent thalassemia patients in recent years has led to the manifestation of morbidities such as renal dysfunction. Renal injury is still an underestimated complication in β thalassemia major patients. Chronic anemia, iron overload due to repeated transfusion, and specific iron chelators are the main factors in pathogenesis of renal dysfunction in β thalass...
متن کاملنقش آدیپوکینها در پاتوفیزیولوژی بیماریهای قلبی-عروقی
Background: Cardiovascular Diseases (CVDs) are major causes of mortality worldwide. Obesity is regarded as an independent CVDs risk factor. In this article we focus on the role of adipokines which are involved in CVDs pathogenesis. Methods: The recent studies regarding the role of adipokines such as Leptin, Resistin, TNF-α, IL-6, MCP-1, Visfatin, Chemerin, Apelin, Omentin, Adipon...
متن کامل